sphs nasdaq

SOPHIRIS BIO INC Share Price - SPHS Share Price

Jun 03, 2021 · The Sophiris Bio Inc PE ratio based on its reported earnings over the past 12 months is 6.56.The shares are currently trading at $0.022.. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors.

SOPHIRIS BIO INC (SPHS) Interactive Stock Chart - Yahoo

Sophiris Bio Inc. (NASDAQ:SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for SOPHIRIS BIO INC (SPHS) Latest Stock News & Headlines Get the latest SOPHIRIS BIO INC (SPHS) stock news and headlines to help you in your trading and investing decisions.

SOPHIRIS BIO INC (SPHS) Stock Forum & Discussion - Yahoo

By David Bautz, PhD NASDAQ:SPHS READ THE FULL SPHS RESEARCH REPORT Business Update Interim Safety and Efficacy Data for Phase 2b Trial of Topsalysin in Localized Prostate Cancer On SOPHIRIS BIO INC (SPHS) Stock Price, News, Quote & History Find the latest SOPHIRIS BIO INC (SPHS) stock quote, history, news and other vital information to help you with your stock trading and investing.

SPHS - Sophiris Bio Stock Price - Barchart

Sophiris Bio Inc. (Nasdaq:SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment SPHS Sophiris Bio Inc. Stock Price and Discussion Jul 02, 2021 · Real-time trade and investing ideas on Sophiris Bio Inc. SPHS from the largest community of traders and investors. Rooms Shows Rankings Earnings Calendar Shop. Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. Sophiris Bio Inc. 0.02 0.00 (11.29%) Watch. Sophiris Bio Inc. OTC Updated Jul 2, 2021 7:36 PM. SPHS 0.02 0

SPHS Sophiris Bio Inc. Analyst Estimates MarketWatch

Jun 05, 2020 · Quarterly Numbers. Actuals. Estimates. SPHS will report Q4 2019 earnings on 08/06/2021. Q4 2018. Q1 2019. Q2 2019. Q3 2019. SPHS Stock Price & Charts Sophiris BioNext Earnings Release:N/A. Last Earnings Release:Nov. 13, 2019. Next Ex-Dividend Date:N/A. Last Ex-Dividend Date:N/A. Description:Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases.

Sophiris Bio Announces Nasdaq Delisting SPHS - Sophiris

Feb 01, 2020 · Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Sophiris Bio Announces Nasdaq DelistingMar 10, 2020 · Sophiris Bio Announces Nasdaq Delisting. SAN DIEGO and VANCOUVER, British Columbia, March 10, 2020 (GLOBE NEWSWIRE) -- Sophiris Bio Inc. (NASDAQ:SPHS) (the "Company" or "Sophiris"), a

Sophiris Bio Announces Nasdaq Delisting

Mar 10, 2020 · Sophiris Bio Inc. (NASDAQ:SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today announced that on March 10, 2020, the Nasdaq Office of General Counsel notified the Company that the Nasdaq Hearing Panel (Panel) had Sophiris Bio Inc. (NASDAQ:SPHS):Sabby Capital Reports Hal Mintzs Sabby Capital recently filed a Form 13G with the SEC, in which it reported the acquisition of 2.48 million common shares of Sophiris Bio Inc. (NASDAQ:SPHS), which amass 8.53% of the

Sophiris Bio Stock Quote. SPHS - NYSE, NASDAQ, AMEX,

SPHS:NASDAQ:Common Stock Price Change Change Percent Stock Price Last Traded ; 0.00:0.0%:0.23:20:00:00:Open Price Low Price High Price Close Price Prev Close; 0.23:0.23:Bid Price Ask Price Spread News; 0.236:0.245:0.009--Last Trade Time Type Quantity Stock Price Currency-0:$ 0.23:USD:Sophiris Bio Financials. Market Cap Shares in Sophiris Bio, Inc. - SPHS - Stock Price Today - ZacksView Sophiris Bio, Inc. SPHS investment & stock information. Get the latest Sophiris Bio, Inc. SPHS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

The Promise Remains Intact for the Sophiris Bio Inc

Aug 30, 2018 · Sophiris Bio Inc (NASDAQ:SPHS) trumpets itself as a clinical-stage biopharmaceutical company that focuses on the development of products for the treatment of urological diseases.Sophiris Bio Inc (SPHS) Press Releases NasdaqMay 18, 2020 · Sophiris Bio Inc (SPHS) Nasdaq Listed. Nasdaq 100. Data is currently not available. $0.0152. -0.0044 (-22.45%) Jun 23, 2021. Add to Watchlist. Add to Portfolio.